Following authorisation from a liberty and custody judge, the Investigation Services of the Autorité de la concurrence carried out an unannounced inspection on 23 September, at the premises of a company suspected of having implemented anticompetitive practices in the cancer treatments sector.



Such an inspection does not prejudge the guilt of the company concerned by the alleged practices, which can only be established following an investigation on the merits.



The Autorité de la concurrence will not comment further, either on the company or on the practices in question.
      
      
      

                
          
  
    Contact(s)
          
                
          
              
          
        
              


      
      
      
  
    
      
            Nicola Crawford
      
      
            Communication officer
      
    
    
      
            +33155040151
      
      
     Contact us by e-mail

French Competition Authority Conducts Inspection in Cancer Treatment Sector

The General Rapporteur of the Autorité de la concurrence has announced that an unannounced inspection took place on September 23rd. This action was authorized by a liberty and custody judge and targeted a company believed to be involved in anticompetitive practices within the cancer treatments sector.

It is important to note that this inspection does not imply any presumption of guilt against the company involved. The determination of guilt will only be made following a thorough investigation into the merits of the case.

The Autorité de la concurrence has stated that it will not provide further comments regarding the company or the specific practices under investigation at this time.



French Competition Authority Conducts Inspection in Cancer Treatment Sector

The French competition authority has conducted an unannounced inspection at a company suspected of anticompetitive practices in the cancer treatments sector.